Patents by Inventor Dimitri LEONOUDAKIS

Dimitri LEONOUDAKIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED TRIAZOLO-PYRIMIDINE COMPOUNDS FOR MODULATING CELL PROLIFERATION, DIFFERENTIATION AND SURVIVAL
    Publication number: 20150307498
    Abstract: Disclosed herein are erythropoietin-mimetic compounds of Formula I, which modulate the survival, function, or differentiation of, for example, kidney cells, neurons, erythroid cells, or other erythropoietin-responsive cells. The present invention also relates to compounds and methods that preferentially modulate cells expressing the tissue-protective erythropoietin receptor. The compounds of the invention are useful in preventing and treating diseases, such as anemia, organ injury, and diseases of the central nervous system, and as an adjunct to cellular treatments, such as stem cell therapies.
    Type: Application
    Filed: November 20, 2013
    Publication date: October 29, 2015
    Inventors: Juha PUNNONEN, Jeffrey R. SPENCER, Timothy J. CHURCH, Connie S. TETTENBORN, Karen Lariosa-Willingham, Dimitri LEONOUDAKIS, James L. MILLER
  • Substituted triazolo-pyrimidine compounds for modulating cell proliferation differentiation and survival
    Patent number: 9163027
    Abstract: Disclosed herein are erythropoietin-mimetic compounds of Formula I, which modulate the survival, function, or differentiation of, for example, kidney cells, neurons, erythroid cells, or other erythropoietin-responsive cells. The present invention also relates to compounds and methods that preferentially modulate cells expressing the tissue-protective erythropoietin receptor. The compounds of the invention are useful in preventing and treating diseases, such as anemia, organ injury, and diseases of the central nervous system, and as an adjunct to cellular treatments, such as stem cell therapies.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: October 20, 2015
    Assignee: STATegics, Inc.
    Inventors: Juha Punnonen, Jeffrey R. Spencer, Timothy J. Church, Connie S. Tettenborn, Karen Lariosa-Willingham, Dimitri Leonoudakis, James L. Miller
  • SUBSTITUTED TRIAZOLO-PYRIMIDINE COMPOUNDS FOR MODULATING CELL PROLIFERATION, DIFFERENTIATION AND SURVIVAL
    Publication number: 20140142122
    Abstract: Disclosed herein are erythropoietin-mimetic compounds of Formula I, which modulate the survival, function, or differentiation of, for example, kidney cells, neurons, erythroid cells, or other erythropoietin-responsive cells. The present invention also relates to compounds and methods that preferentially modulate cells expressing the tissue-protective erythropoietin receptor. The compounds of the invention are useful in preventing and treating diseases, such as anemia, organ injury, and diseases of the central nervous system, and as an adjunct to cellular treatments, such as stem cell therapies.
    Type: Application
    Filed: November 20, 2013
    Publication date: May 22, 2014
    Applicant: STATegics, Inc.
    Inventors: Juha PUNNONEN, Jeffrey R. SPENCER, Timothy J. CHURCH, Connie S. TETTENBORN, Karen LARIOSA-WILLINGHAM, Dimitri LEONOUDAKIS, James L. MILLER